Details for Patent: 8,474,447
✉ Email this page to a colleague
Which drugs does patent 8,474,447 protect, and when does it expire?
Patent 8,474,447 protects ATROVENT HFA and is included in one NDA.
This patent has ten patent family members in nine countries.
Summary for Patent: 8,474,447
| Title: | Inhaler device |
| Abstract: | The invention relates to a hand-held device (1), as depicted in exemplary FIG. 4, for metered dispensing of sprayable substances, particularly medicaments for inhalation, with a cartridge (3) that can be moved into the dispensing position, by pressure being applied to a housing, and with a step-by-step indexing mechanism (11) which is entrained by the cartridge (3) in the opening travel thereof and which is used to record and display the dispensing actuations that have been performed. In order to suitably design a hand-held device of the type in question with a simplified structure, in such a way that the indexing steps can be performed smoothly and safely without connection to the cartridge, it is proposed that slits (19) extend obliquely only over part of the travel of the step-by-step indexing mechanism housing (34) and that the guide pins (33) guided therein move, over the remainder of the travel of the step-by-step indexing mechanism (11), parallel to the longitudinal axis (x-x) of the step-by-step indexing mechanism. |
| Inventor(s): | Alfred Von Schuckmann, Dieter Hochrainer, Hubert Hoelz |
| Assignee: | Boehringer Ingelheim International GmbH |
| Application Number: | US12/677,555 |
|
Patent Claim Types: see list of patent claims | Device; |
Drugs Protected by US Patent 8,474,447
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | ATROVENT HFA | ipratropium bromide | AEROSOL, METERED;INHALATION | 021527-001 | Nov 27, 2004 | AB | RX | Yes | Yes | 8,474,447 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,474,447
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2007 045 438 | Sep 22, 2007 |
| PCT Information | |||
| PCT Filed | August 28, 2008 | PCT Application Number: | PCT/EP2008/061337 |
| PCT Publication Date: | March 26, 2009 | PCT Publication Number: | WO2009/037085 |
International Family Members for US Patent 8,474,447
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2700201 | ⤷ Start Trial | |||
| Germany | 102007045438 | ⤷ Start Trial | |||
| Denmark | 2203205 | ⤷ Start Trial | |||
| European Patent Office | 2203205 | ⤷ Start Trial | |||
| Spain | 2539285 | ⤷ Start Trial | |||
| Hungary | E025069 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
